{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:45:29Z","timestamp":1784771129457,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007184","name":"Yale School of Medicine","doi-asserted-by":"publisher","award":["T35HL007649"],"award-info":[{"award-number":["T35HL007649"]}],"id":[{"id":"10.13039\/100007184","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.prro.2023.11.006","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T03:24:28Z","timestamp":1700364268000},"page":"e97-e104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-203X","authenticated-orcid":false,"given":"Alexander","family":"Sasse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel X.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Hayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin A.","family":"Knowlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle W.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Housri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9366-8514","authenticated-orcid":false,"given":"Henry S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2023.11.006_bib0001","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijrobp.2010.08.056","article-title":"A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"82","author":"Barriger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.11.006_bib0002","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.ijrobp.2012.01.018","article-title":"Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"83","author":"Matsuo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.11.006_bib0003","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.prro.2016.01.015","article-title":"Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy","volume":"6","author":"Harder","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2023.11.006_bib0004","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.19.01162","article-title":"Long-term results of NRG Oncology RTOG 0617: Standard versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer","volume":"38","author":"Bradley","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.11.006_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.prro.2023.04.003","article-title":"Consensus quality measures and dose constraints for lung cancer from the veterans affairs radiation oncology quality surveillance program and ASTRO expert panel","volume":"13","author":"Puckett","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2023.11.006_bib0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2013.10.011","article-title":"Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs","volume":"109","author":"Bongers","year":"2013","journal-title":"Radiother Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.prro.2023.11.006_bib0007","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.11.006_bib0009","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2023.11.006_bib0010","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ijrobp.2023.06.246","article-title":"Expanded HILUS trial: A pooled analysis of risk factors for toxicity from stereotactic body radiation therapy of central and ultracentral lung tumors","volume":"117","author":"Lindberg","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16 suppl","key":"10.1016\/j.prro.2023.11.006_bib0011","doi-asserted-by":"crossref","first-page":"8513","DOI":"10.1200\/JCO.2022.40.16_suppl.8513","article-title":"Safety results of NRG-LU004: Phase I trial of accelerated or conventionally fractionated radiotherapy combined with durvalumab in PD-L1\u2013high locally advanced non-small cell lung cancer","volume":"40","author":"Lin","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.11.006_bib0012","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jamaoncol.2021.3186","article-title":"Accelerated hypofractionated image-guided versus conventional radiotherapy for patients with stage II\/III non-small cell lung cancer and poor performance status: A randomized clinical trial","volume":"7","author":"Iyengar","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2023.11.006_bib0013","unstructured":"Testing the addition of the drug atezolizumab to the usual radiation treatment for patients with early non-small cell lung cancer: Available at: https:\/\/classic.clinicaltrials.gov\/show\/NCT04214262. Accessed 30 August, 2023."},{"key":"10.1016\/j.prro.2023.11.006_bib0014","unstructured":"Study of radiation therapy followed by atezolizumab in stage II or III non-small cell lung cancer patients. Available at: https:\/\/classic.clinicaltrials.gov\/show\/NCT04310020. Accessed 2 September, 2023."},{"key":"10.1016\/j.prro.2023.11.006_bib0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2016.03.013","article-title":"Normal tissue considerations and dose-volume constraints in the moderately hypofractionated treatment of non-small cell lung cancer","volume":"119","author":"Fleming","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2023.11.006_bib0016","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1748-717X-8-201","article-title":"Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy\/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: A phase I trial","volume":"8","author":"Lin","year":"2013","journal-title":"Radiat Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850023003041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850023003041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T11:08:11Z","timestamp":1745665691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850023003041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1879850023003041"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2023.11.006","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}